Development of Pure Prolactin Receptor Antagonists
Sophie Bernichtein(Inserm), Vincent Goffin(Centre National de la Recherche Scientifique), Stéphanie Moulin(Inserm), John J. Kopchick(University of Maryland, Baltimore), Paul A. Kelly(MRC Centre for Reproductive Health), Karin Dillner(Karolinska University Hospital), Christine Kayser(Inserm), Olle Isaksson(University of Gothenburg), Joseph Martial(University of Liège), Gunnar Norstedt(Karolinska University Hospital)
Cited by 128
Related Papers
Treatment of Deep Cartilage Defects in the Knee with Autologous Chondrocyte Transplantation
|New England Journal of Medicine|1994|5.5k
Liver-derived insulin-like growth factor I (IGF-I) is the principal source of IGF-I in blood but is not required for postnatal body growth in mice
|Proceedings of the National Academy of Sciences|1999|956
Guidelines of the Pituitary Society for the diagnosis and management of prolactinomas
|Clinical Endocrinology|2006|830
Growth Hormone and Bone*
|Endocrine Reviews|1998|808
Treatment of adults with growth hormone (GH) deficiency with recombinant human GH.
|The Journal of Clinical Endocrinology & Metabolism|1993|781